GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Sep. 25, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The following table provides a rollforward of the Company’s goodwill:


			Adjustments to Goodwill
	December 26, 2020		Acquisitions		Foreign Exchange		Other1		September 25, 2021
	(in thousands)
RMS	$	287,759	$	—	$	(29)	$	(6,876)	$	280,854
DSA	1,378,130		123,092		(11,436)		—		$	1,489,786
Manufacturing	143,279		851,614		(2,610)		(26,601)		$	965,682
Goodwill	$	1,809,168	$	974,706	$	(14,075)	$	(33,477)	$	2,736,322

The increase in goodwill during the nine months ended September 25, 2021 related primarily to the acquisitions of Cognate and Vigene in the Manufacturing reportable segment and Distributed Bio and Retrogenix in the DSA reportable segment.

1On October 12, 2021, the Company divested two businesses (see Note 18 “Subsequent Events”) and reclassified the related goodwill to assets held for sale as of September 25, 2021.

Intangible Assets, Net

The following table displays intangible assets, net by major class:


	September 25, 2021						December 26, 2020
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
	(in thousands)
Backlog	$	11,874	$	(8,019)	$	3,855	$	29,233	$	(29,233)	$	—
Technology	137,753		(92,884)		44,869		130,907		(81,305)		49,602
Trademarks and trade names	13,188		(3,074)		10,114		15,870		(5,648)		10,222
Other	35,331		(6,895)		28,436		20,903		(14,633)		6,270
Other intangible assets	198,146		(110,872)		87,274		196,913		(130,819)		66,094
Client relationships	1,497,255		(484,649)		1,012,606		1,137,331		(415,826)		721,505
Intangible assets	$	1,695,401	$	(595,521)	$	1,099,880	$	1,334,244	$	(546,645)	$	787,599

The increase in intangible assets, net during the nine months ended September 25, 2021 related primarily to the acquisitions of Cognate, Distributed Bio, Retrogenix, and Vigene. Certain intangibles assets were reclassified to assets held for sale as of September 25, 2021 in connection with two divestitures that occurred on October 12, 2021. See Note 18 “Subsequent Events”